Checkpoint Trends P/E Ratio
Current P/E Ratio
12.22
Low Valuation
Low - May indicate good value opportunity
Checkpoint Trends P/E ratio. Checkpoint Trends (CHECKPOINT) P/E ratio is 12.22 (Low), EPS (TTM) ₹0.05, current price ₹41.69 on BSE — Low - May indicate good value opportunity. Check CHECKPOINT market value to track the company's total market size over time.
Current Valuation Metrics
P/E Ratio
12.22
Current Price
₹41.69
EPS (TTM)
₹0.05
Exchange
BSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
52.35
Sector Median
29.6
Sector Rank
#11 of 255
Sector Percentile
4.3%
CHECKPOINT P/E Ratio — Valuation Signal & Historical Context
Checkpoint Trends P/E 12.22 — signal: Fairly Valued. For live price, revenue and the complete fundamental profile, see CHECKPOINT share price screener.
- Stock appears undervalued with PE of 12.22, suggesting potential buying opportunity
- Trading at discount to sector average PE of 52.35
CHECKPOINT vs Healthcare Peers — P/E Ratio Comparison
Checkpoint Trends P/E 12.22 vs Healthcare average 52.35, median 29.6 — range 2.0–733.0.
Sector Average
52.35
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |